Laboratory Corporation of America Holdings (NYSE: LH) has completed its $1.2 billion takeover of Chiltern International Ltd, the Burlington-based company said Friday. The acquisition expands LabCorp's reach into the contract-research sector. The company announced the deal in July and received regulatory approval for the acquisition last week. "The addition of Chiltern advances a key element of LabCorp's strategy - to bring innovative medicines to patients faster which ultimately will improve...
Chiltern is a contract research organization that provides clinical development services for diagnostics, pharmaceuticals and biotechnology industries.